WHO Removes Remdesivir From List of COVID-19 Medicines

The World Health Organisation (WHO) has stated that it has suspended Gilead Sciences’ antiviral drug remdesivir, which was touted as COVID-19 treatment, from its prequalification list—- an official list of medicines used as a benchmark for procurement by developing countries.

In an emailed response to news agency Reuters, WHO spokesperson Tarik Jasarevic said,”Yes we have suspended it from the PQ (prequalification list). The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for COVID

Earlier on Friday, the WHO had warned that the antiviral drug remdesivir should not be used to treat COVID patients, no matter how ill they are as there is no evidence it works





Leave a Reply

Your email address will not be published. Required fields are marked *